General Information
An educational meeting series addressing the most controversial areas of current management
Tuesday, October 19, 2010
6:00 pm – 8:30 pm
Course Director:
Jorge Cortes, MD
University of
Texas
M.D. Anderson Cancer Center
Houston, Texas
Venue
Escopazzo
1311 Washington Ave. (between 13th & 14th Sts)
Miami Beach, FL 33139
Phone: 305-674-9450
www.escopazzo.com
Parking
Valet parking is available for $15.00 per car. Street parking is also available with either the outdoor metered municipal lot around the corner at 13th and Collins or indoor parking garages available within two blocks. The meeting organizer is not responsible for any parking costs.
Corporate Support
The following company has provided an educational grant in support of this conference:
Continuing Medical Education
Imedex®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Imedex, LLC designates this educational activity for a maximum of 2.0 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Who Should Attend
This educational activity is specifically designed for hematologists, oncologists, and other physicians, clinicians, physicians-in-training, and healthcare professionals (oncology nurses, pharmacists, physician assistants) involved and/or interested in the therapeutic management of patients with CML.
Objectives
After successful completion of this course, participants should be able to:
- Identify two practical recommendations for monitoring response and assessing progression in CML patients
- Comment on at least two strategic plans for the management of CML patients who exhibit suboptimal response to treatment.
- Review three second-line therapy options for patients with suboptimal response or who have failed front-line therapy
- Identify two strategic options for choosing front-line CML therapy
Conference Organizer
4325 Alexander Drive
Alpharetta, Georgia
30022-3740, USA
Tel.: +1 (770) 751 7332
Fax: +1 (770) 751 7334
Email: meetings@imedex.com
www.imedex.com
Faculty
H. Jean Khoury, MD, FACP
Winship Cancer Institute of Emory University
Atlanta, Georgia
Javier Pinilla-Ibarz, MD, PhD
H. Lee Moffitt Cancer Center and Research Institute
Tampa, Florida
Scientific Agenda
| 6:00 pm | Dinner served |
| 6:30 pm | Welcome and pre-activity knowledge/competence assessment via ARS |
| 6:40 pm | Monitoring response in TKI therapy - Practical recommendations for the practicing hematologist Javier Pinilla-Ibarz, MD, PhD |
| 7:00 pm | Case presentation: Effectively diagnosing and managing suboptimal response H. Jean Khoury, MD, FACP |
| 7:25 pm | Case presentation: Selecting the optimal second-line therapy for patients with a suboptimal response or who have failed front-line therapy Javier Pinilla-Ibarz, MD, PhD |
| 7:50 pm | Debate: Is it time to move beyond first generation TKIs in frontline therapy of CP-CML? |
| Point: Imatinib is the proven standard of care for nearly all newly diagnosed patients Javier Pinilla-Ibarz, MD, PhD |
|
| Counterpoint: It is time to institute frontline therapy with second generation TKIs H. Jean Khoury, MD, FACP |
|
| 8:20 pm | Conclusive message and post-activity knowledge/competence assessment via ARS |
| 8:30 pm | Adjourn |
Registration Procedures
This is a complimentary educational dinner meeting for physicians and nurses. There is no cost to attend this activity or to obtain CME credits.
Register
To Register:
Register online by Wednesday, October 13, 2010 or by returning the registration form in this program by mail or fax. If you mail the form, please keep a copy for your records. Registration confirmations will be issued before the meeting.
